← Leaderboards
Timothy Ross Morgan
University Of California, San Diego
$3,782,658
Attributed
$6,700,524
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2008–19$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,700,524 · 7
By mechanism
U01$6,246,272 · 3
R01$336,491 · 1
M01$117,761 · 3
Top collaborators
- Devanshi Seth7 shared
- John B Whitfield7 shared
- Suthat Liangpunsakul6 shared
- Christopher Paul Day5 shared
- Paul Steven Haber5 shared
- Bertrand Nalpas5 shared
- Felix Stickel5 shared
- Sebastian Mueller4 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- David L Wyles$2,747,228
- Ajay R Bharti$3,656,410
- Lori Broderick$1,549,652
- Pradipta Ghosh$13,342,507
- Adriana H Tremoulet$8,401,727
Others in their field
Top investigators on “Problem Drinker”
- Adolf Pfefferbaum · Sri International$25,996,151
- Hidekazu Tsukamoto · Va Greater Los Angeles Healthcare System$20,645,287
- Bernice Porjesz · Suny Downstate Medical Center$15,051,296
- George Fein · Northern California Institute Res &Educ$13,387,536
- David A Kareken · Indiana University Indianapolis$11,700,012
- Andrea C King · University Of Chicago$11,349,945
Research focus
Problem DrinkerLiver DiseasesReportingPathway InteractionsInflammatoryHepaticInflammationMinorityResearch PersonnelLeadClinical TrialsPharmaceutical PreparationsLiverInfectionInjuryData AnalysesAlcoholic Liver DiseasesCirrhosisChronicProspectiveDesignAlcoholic HepatitisCytokineCessation Of Life
Grant awards (19)
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$336,491
R01 · FY2019 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$373,523
U01 · FY2018 · AA · contact PI
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph$370,718
U01 · FY2017 · AA · contact PI
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph$698,450
U01 · FY2016 · AA · contact PI
Southern California Alcoholic Hepatitis Consortium Administrative Core$29,986
U01 · FY2016 · AA · contact PI
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph$677,495
U01 · FY2015 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$458,729
U01 · FY2015 · AA · contact PI
Southern California Alcoholic Hepatitis Consortium Administrative Core$29,086
U01 · FY2015 · AA · contact PI
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph$676,427
U01 · FY2014 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$518,642
U01 · FY2014 · AA · contact PI
Southern California Alcoholic Hepatitis Consortium Administrative Core$29,086
U01 · FY2014 · AA · contact PI
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph$724,843
U01 · FY2013 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$518,431
U01 · FY2013 · AA · contact PI
Southern California Alcoholic Hepatitis Consortium Administrative Core$29,986
U01 · FY2013 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$552,182
U01 · FY2012 · AA · contact PI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study$558,688
U01 · FY2011 · AA · contact PI
CLINICAL TRIAL: HALT-C$5,672
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: HALT-C$45,412
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: HALT-C$66,677
M01 · FY2008 · RR · contact PI